Maryam Lustberg, Director of Breast Center/Chief Breast Oncology at Yale University School of Medicine, shared a post on LinkedIn about a recent paper by Christina Mayerhofer et al. published in Journal of Clinical Oncology:
“More studies are necessary to further define the implications of clonal hematopoiesis in patients with breast cancer and guide clinical decision making.”
“Clonal Hematopoiesis in Women With Breast Cancer”
Authors: Christina Mayerhofer, Rachel Freedman, Heather Parsons, Ann Partridge, Peter Miller.
More posts featuring Maryam Lustberg.